While Genomics Shares Seek Their Floor, Analysts Start Talking Takeovers | GenomeWeb

NEW YORK, March 21 – With genomics stocks continuing to drop, the possibility for potential takeover bids is increasing, analysts said Wednesday. 

“I definitely think there is an opportunity to acquire good biotech companies with good technology and balance sheets,” said Andrew Scott, an analyst at M. H. Meyerson in New York.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.